Quick Answer
Greenwich LifeSciences, Inc. reported Common Stock Shares Outstanding of 13.15 million shares for the year ending 2024.
- Greenwich LifeSciences, Inc. showed an increase of +2.4% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from Greenwich LifeSciences, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: 11.97 million shares | Q1 2021: 12.85 million shares | Q2 2021: 12.92 million shares | Q3 2021: 12.99 million shares | Q1 2022: 12.95 million shares | Q2 2022: 12.77 million shares | Q3 2022: 12.85 million shares | Q1 2023: 12.85 million shares | Q2 2023: 12.85 million shares | Q3 2023: 12.85 million shares | Q1 2024: 12.88 million shares | Q2 2024: 13.07 million shares | Q3 2024: 13.14 million shares | Q4 2024: 13.15 million shares | Q1 2025: 13.19 million shares | Q2 2025: 13.47 million shares | Q3 2025: 13.79 million shares.
- Over the full 6 years of available data (2019 to 2024), Greenwich LifeSciences, Inc.'s Common Stock Shares Outstanding has grown by 55.5%.
- Historical annual values: Fiscal year 2024: 13.15 million shares | Fiscal year 2023: 12.85 million shares | Fiscal year 2022: 12.85 million shares | Fiscal year 2021: 13.15 million shares | Fiscal year 2020: 12.70 million shares | Fiscal year 2019: 8.46 million shares.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: